News | Stroke | March 12, 2019

Iron Measurements With MRI Reveal Stroke's Impact on Brain

MRI technique called R2* mapping may reveal stroke damage remote from the infarct

Iron Measurements With MRI Reveal Stroke's Impact on Brain

Images show illustrative examples of visual R2? modifications within substantia nigra (SN) at baseline (24-72 h) and follow-up (1 y) in striatum (participants 1 and 2) and control groups (participants 3 and 4). Image courtesy of the Radiological Society of North America (RSNA).

March 12, 2019 — A simple magnetic resonance imaging (MRI) method that measures iron content can provide a more comprehensive picture of the consequences of stroke-related damage to the brain, according to a study published in the journal Radiology.1 Researchers said the findings point to a role for MRI brain iron measurements in monitoring recovery from stroke.

Strokes can result in significant impairments caused by infarctions, or the death of tissue due to the brain’s blood supply being blocked by a clot. Long-term outcomes may also be affected by delayed degeneration of brain areas away from the location of the stroke. One such area is the substantia nigra (SN), a structure of the midbrain that is connected with other parts of the brain in several complex networks.

“Overall, the SN is strongly involved in motor control, but also in regulation of emotions, cognition and motivation,” said study co-author Thomas Tourdias, M.D., Ph.D., professor of radiology at the Centre Hospitalier Universitaire in Bordeaux, France. “Usually, stroke doesn’t directly affect the SN but, by interrupting circuits, stroke can induce secondary degeneration of that area.”

Prior to the new study, this secondary degeneration of SN had only been seen on post-mortem brain examinations. Imaging on a living person has not been able to capture the long-term degeneration, so for the new study, Tourdias and colleagues employed an MRI technique that measures iron content in the brain. Iron is important for normal brain function, but an excess of it has been linked to neurodegeneration. Iron is released from dying neurons and iron-rich immune cells present around injured neurons. The excess iron further accelerates neurodegeneration through a process called oxidative stress.

The researchers used an MRI technique called R2* mapping to evaluate 181 patients who had suffered a stroke. One year after a baseline evaluation, some of the patients showed higher iron content in the SN. This high iron content was associated with worse long-term outcomes, particularly when it was found on the same side of the brain that the stroke occurred.

“We showed that imaging of iron can also be used to image degeneration remotely from stroke in disconnected areas,” Tourdias said. “This finding could be clinically useful because it shows that a simple magnetic resonance imaging method such as R2* can provide a more comprehensive picture of the consequences of an infarct.”

The results suggest that R2* mapping may be added to the follow-up MRI after stroke to monitor neurodegeneration, Tourdias said, by assessing iron levels in the SN. More generally, the findings lend support to the use of iron imaging as a marker for neurodegeneration, an idea that is already being explored for neurodegenerative diseases like Parkinson’s disease. Therapies that prevent iron deposition could potentially be used to slow or stop the degeneration of the neurons.

“We are currently investigating this direction,” Tourdias said. “Our imaging approach could become crucial in the clinic if modulation of iron develops as a neuroprotective strategy in the future.”

For more information: www.pubs.rsna.org/journal/radiology

Reference

1. Linck P.A., Kuchcinski G., Munsch F., et al. Neurodegeneration of the Substantia Nigra after Ipsilateral Infarct: MRI R2* Mapping and Relationship to Clinical Outcome. Radiology, March 12, 2019. https://doi.org/10.1148/radiol.2019182126

Related Content

MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Brazil's Santa Casa Hospital System Chooses Carestream for Unified Diagnostic Workflow
News | PACS | May 22, 2019
Santa Casa de Misericordia has selected Carestream to replace its legacy diagnostic workflow technology across all...
Philips Lumify Earns U.S. Army Airworthiness Certification
News | Ultrasound Imaging | May 22, 2019
Philips announced that Philips Lumify, a point-of-care ultrasound device, has earned the U.S. Army Airworthiness...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
Life Image and Bialogics Analytics Partner to Deliver Imaging Business Intelligence
News | Analytics Software | May 21, 2019
Life Image and business intelligence analytics provider Bialogics Analytics have formed a strategic partnership that...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...